Patent US6882874B2 successfully refreshed from Google Patents.
US6882874B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compensation of human variability in pulse oximetry
Assignee: Datex Ohmeda Inc
•
Filing: 2002-02-15
•
Granted: 2005-04-19
•
Expires: 2022-02-15
Abstract
Abstract The invention relates to the calibration of a pulse oximeter intended for non-invasively determining the amount of at least two light-absorbing substances in the blood of a subject. In order to bring about a solution by means of which the effects caused by the tissue of the subject can be taken into account in connection with the calibration of a pulse oximeter, initial characterization measurements are carried out for a pulse oximeter calibrated under nominal conditions. Based on the characterization measurements, nominal characteristics are established describing the conditions under which nominal calibration has been defined, and reference data indicating the nominal characteristics are stored. In-vivo measurements are then performed on living tissue and based on the in-vivo measurements and the reference data stored, tissue-induced changes in the nominal characteristics are determined. Subject-specific variation in the in-vivo measurements is compensated for by correcting the nominal calibration on the basis of the tissue-induced changes.
Inventors
- 👤 Matti Huiku
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 19:25
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/14551; A61B5/1495
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
179 words
A method for compensating for subject-specific variability in an apparatus intended for non-invasively determining the amount of at least two light-absorbing substances in the blood of a subject and provided with emitter means for emitting radiation at a minimum of two different wavelengths and with detector means for receiving the radiation emitted, the method comprising the steps of calibrating the apparatus using a nominal calibration, carrying out initial characterization measurements, said measurements to include measuring radiation emitted by said emitter means and received by the detector means without transmission through tissue, based on the characterization measurements, establishing nominal characteristics describing conditions under which the nominal calibration is used, storing reference data indicating the nominal characteristics established, performing in-vivo measurements on living tissue, wherein radiation emitted by the emitter means through the living tissue and received by the detector means is measured, based on the in-vivo measurements and the reference data stored, determining tissue-induced changes in the nominal characteristics, and compensating for subject-specific variation in the in-vivo measurements by correcting the nominal calibration on the basis of the tissue-induced changes.
Claim 2
Independent Claim
179 words
A method for compensating for subject-specific variability in an apparatus intended for non-invasively determining the amount of at least two light-absorbing substances in the blood of a subject and provided with emitter means for emitting radiation at a minimum of two different wavelengths and with detector means for receiving the radiation emitted, the method comprising the steps of calibrating the apparatus using a nominal calibration, carrying out initial characterization measurements, said measurements to include measuring radiation emitted by said emitter means and received by the detector means without transmission through tissue, based on the characterization measurements, establishing nominal characteristics describing conditions under which the nominal calibration is used, storing reference data indicating the nominal characteristics established, performing in-vivo measurements on living tissue, wherein radiation emitted by the emitter means through the living tissue and received by the detector means is measured, based on the in-vivo measurements and the reference data stored, determining tissue-induced changes in the nominal characteristics, and compensating for subject-specific variation in the in-vivo measurements by correcting the nominal calibration on the basis of the tissue-induced changes.
Claim 3
Dependent Claim
14 words
A method according to claim 1 , including compensation for effects causing wavelength shift.
Claim 4
Dependent Claim
23 words
A method according to claim 2 , wherein the compensation for effects causing wavelength shift includes defining subject-specific extinction coefficients for the substances.
Claim 5
Dependent Claim
37 words
A method according to claim 3 , wherein said establishing step includes determining DC transmission characteristics of the emitter and detector means, spectral characteristics of the emitter and detector means and nominal transmission characteristics for the tissue.
Claim 6
Dependent Claim
23 words
A method according to claim 4 , wherein said establishing step further includes determining a temperature in which the nominal calibration is used.
Claim 7
Dependent Claim
145 words
A method according to claim 5 , wherein the extinction coefficients ε ij are determined according to the following formula: ɛ ij effective = 1 W ∫ Δ λ ɛ j ( λ ) * LED i ( λ ( T ) ) * DET ( λ ) * tissue ( λ ) ∂ λ , where ε ij effective is the effective extinction for the emitter means as defined by the integration over an emission spectrum LED i (λ) of the emitter means, DET(λ) represents a spectral sensitivity of the detector means, tissue(λ) is a spectral transmission of radiation through the tissue, ε j is the extinction coefficient of the substance, T is a temperature, λ is a wavelength of the radiation, W is a normalization factor, and i and j are matrix indices.
Claim 8
Dependent Claim
58 words
A method according to claim 6 , wherein the step of establishing nominal characteristics includes defining a nominal extinction matrix with a nominal extinction coefficient for each substance/wavelength pair, and the step of determining tissue-induced changes includes updating the nominal extinction matrix, whereby the updated matrix includes the subject-specific extinction coefficients to be used in the Lambert-Beer model.
Claim 9
Dependent Claim
102 words
A method according to claim 7 , wherein the nominal extinction matrix is determined according to the following formula ɛ ij effective = 1 W ∫ Δ λ ɛ j ( λ ) * LED i ( λ ( T ) ) * DET ( λ ) ∂ λ where the integration is over the emission spectrum LED i (λ) of the emitter means, DET(λ) represents the spectral sensitivity of the detector means; ε j is the extinction coefficient of the substance, T is the temperature, and i and j are matrix indices.
Claim 10
Dependent Claim
48 words
A method according to claim 7 , wherein the step of establishing nominal characteristics further includes determining a first shift matrix, the elements of which indicate a relative change in each extinction coefficient, assuming that the slope of the term tissue(λ) has a fixed value deviating from zero.
Claim 11
Dependent Claim
42 words
A method according to claim 9 , wherein the step of determining tissue-induced changes in the nominal characteristics includes defining (1) the slope of the term tissue(λ) and (2) the subject-specific extinction coefficients based on the shift matrix and the slope defined.
Claim 12
Dependent Claim
38 words
A method according to claim 6 , wherein the step of establishing nominal characteristics further includes defining temperature dependence of the emitter and detector means, and said compensating step includes temperature compensation for the emitter and detector means.
Claim 13
Dependent Claim
38 words
A method according to claim 11 , wherein the step of establishing nominal characteristics further includes determining a second shift matrix the elements of which indicate a relative change of each extinction coefficient for a predetermined wavelength shift.
Claim 14
Dependent Claim
40 words
A method according to claim 12 , wherein the step of determining tissue-induced changes in the nominal characteristics includes defining a wavelength shift caused by temperature and defining subject-specific coefficients based on the shift matrix and the wavelength shift defined.
Claim 15
Dependent Claim
15 words
A method according to claim 1 , including compensation for effects internal to the tissue.
Claim 16
Dependent Claim
31 words
A method according to claim 14 , wherein the compensation for effects internal to the tissue includes defining a subject-specific transformation used to transform in-vivo measurement results to the Lambert-Beer model.
Claim 17
Dependent Claim
44 words
A method according to claim 15 , wherein the method further includes the steps of storing an average transformation measured for a great number of subjects and based on the tissue-induced changes, updating the average transformation, whereby the updated transformation represents the subject-specific transformation.
Claim 18
Dependent Claim
22 words
A method according to claim 1 , including both compensation for effects causing wavelength shift and for effects internal to the tissue.
Claim 19
Dependent Claim
47 words
A method according to claim 17 , wherein the compensation for effects causing wavelength shift includes defining subject-specific extinction coefficients for the substances, and the compensation for effects internal to the tissue includes defining a subject-specific transformation used to transform in-vivo measurement results to the Lambert-Beer model.
Claim 20
Dependent Claim
65 words
A method according to claim 18 , wherein the step of defining nominal characteristics includes calculating nominal values for the Functional Light Transmission (FLT) of the apparatus, the step of determining tissue-induced changes includes calculating new values for the Functional Light Transmission (FLT) of the apparatus, and the step of compensating includes determining the subject-specific transformation on the basis of the nominal and new values.
Claim 21
Dependent Claim
144 words
A method according to claim 18 , wherein the step of defining nominal characteristics includes calculating nominal values for function F kl of the apparatus, the step of determining tissue-induced changes includes calculating new values for the function F kl of the apparatus, and the step of compensating includes determining the subject-specific transformation on the basis of the nominal and new values, wherein the function F kl corresponds to the ratio f a ( μ a k - μ v k ) + μ v k f a ( μ a l - μ v l ) + μ v l , where μ v and μ a are the absorption coefficients of venous and arterial blood, respectively, as determined in the Lambert-Beer domain, f a is the volume fraction of arterial blood, and the superscripts k and l indicate the wavelength.
Claim 22
Dependent Claim
38 words
A method according to claim 20 , wherein the nominal and new values for the Function F kl are calculated on the basis of measured fluctuation of the DC component of the radiation received by the detector means.
Claim 23
Dependent Claim
40 words
A method according to claim 20 , wherein the step of determining tissue-induced changes includes calculating a first approximation for the amount of the substances, and the step of compensating includes utilizing the first approximation for determining the subject-specific transformation.
Claim 24
Dependent Claim
22 words
A method according to claim 1 , wherein the at least two light absorbing substances include oxyhemoglobin (HbO2) and reduced hemoglobin (RHb).
References Cited (Backward Citations)
US4086915A
Cited
US4933614A
Cited
US4968137A
Cited
US5499627A
Cited
US5278627A
Cited
US5357953A
Cited
US6061581A
Cited
US5630413A
Cited
US5355880A
Cited
US5792050A
Cited
US6073037A
Cited
US5348003A
Cited
US5692503A
Cited
US5725480A
Cited
US5931779A
Cited
US6104938A
Cited
US6163715A
Cited
US5842979A
Cited
US5891024A
Cited
WO2001003577A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2008-04-18 | 2008-10-18 | 2009-04-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2012-04-18 | 2012-10-18 | 2013-04-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2016-04-18 | 2016-10-18 | 2017-04-19 | $7700.00 | Window Closed / Lapsed |